Walsby, E., Pearce, L., Burnett, A. K., Fegan, C., & Pepper, C. (2012). The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. Impact Journals LLC.
Citação norma ChicagoWalsby, Elisabeth, Lawrence Pearce, Alan K. Burnett, Chris Fegan, and Chris Pepper. The Hsp90 Inhibitor NVP-AUY922-AG Inhibits NF-κB Signaling, Overcomes Microenvironmental Cytoprotection and Is Highly Synergistic With Fludarabine in Primary CLL Cells. Impact Journals LLC, 2012.
MLA citiranjeWalsby, Elisabeth, et al. The Hsp90 Inhibitor NVP-AUY922-AG Inhibits NF-κB Signaling, Overcomes Microenvironmental Cytoprotection and Is Highly Synergistic With Fludarabine in Primary CLL Cells. Impact Journals LLC, 2012.